FDA 483 - Vitalant - June 19, 2019

An FDA inspection of Vitalant, a blood bank and donor collection center in Lafayette, LA, identified a failure to maintain quality control records. Specifically, the firm lacked documentation of antigen typing quality control results for specific antigens on multiple dates. This indicates a deficiency in record-keeping practices for critical quality control procedures.